Announcing the winners of our #EASLshare competition
As a fully digital three-day event, Digital ILC 2020 brought together thousands of delegates from all over the world. EASL invited you, the delegates, to take part in the first ever EASL…
Patients, science, and policy forging positive change for public health
On 4 November 2020, EASL held its first online Patient Forum, a vibrant exchange exploring synergies between our association of professionals and regional patient organisations engaged in the fight against liver disease.…
Register for our nurses & AHPs webinar on Sarcopenia in chronic liver disease. Free access.
Save the date and register for the first webinar. Free access. Topic: Sarcopenia in chronic liver disease When: Thursday, 12th Nov. 2020 from 8 pm to 9.30 pm CET Learning objectives: To…
Muscle weakness and frailty adversely affect late-stage liver disease, study finds
AMRA Medical Research Results Support Strengthening Sarcopenia Guidelines AMRA Medical’s research publication in JHEP Reports details the link between MRI-based adverse muscle composition and NAFLD metabolic comordidity & poor function. Linköping, Sweden,…
Autumn 2020 offers a crop of EASL hepatology fellowships
From ground-breaking discoveries to the Nobel Prize 2020, hepatology is cutting edge. This autumn, EASL has a crop of exciting fellowships on offer, to foster the next generation of bright minds. Are…
Hepatitis C scientists in the limelight: Nobel Prize 2020
5 October 2020 The Nobel Prize in Physiology or Medicine 2020 has been awarded jointly to Harvey J. Alter, Michael Houghton, and Charles M. Rice for the discovery of hepatitis C virus…
Patients with cirrhosis at increased risk of death from COVID-19, study finds
An international study led by researchers at Oxford University Hospitals NHS Foundation Trust has shown that patients with cirrhosis are at increased risk of dying as a result of COVID-19. Oxford, October…